Pr Philippe Moreau
- Specialty
- Hematologist, multiple myeloma expert
- Hospital
- Centre Hospitalier Universitaire de Nantes
- Latest articles
-
- Talquetamab for people living with relapsed/ refractory multiple myeloma: plain language summary of the MonumenTAL-1 study. (Aug 30, 2026)
- Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis. (Aug 24, 2026)
- Blood-based MALDI-TOF mass spectrometry versus bone marrow MRD for monitoring multiple myeloma: CASSIOPEIA study results. (Aug 17, 2026)
- Clinical outcomes of newly diagnosed myeloma patients with SLIM criteria : a subgroup analysis of the CASSIOPEIA study. (Aug 13, 2026)
- Hospital at Home for BCMA-Directed Bispecific Antibodies in Multiple Myeloma: A Multicenter Real-World Feasibility and Safety Study. (Jul 28, 2026)